What if we applied this to all patients? What could we learn from including all plans in the analysis? With the help of machine learning, outcome studies have the potential to expand to more sites and varying patient qualities.
As clinicians, we will not directly benefit from complying to standardized nomenclature. This is a small step we can take towards better outcomes studies for patients that will be treated in your clinic and in clinics around the world.
Additional reading for your physicians:
New Cancer Treatments Lie Hidden Under Mountains of Paperwork via The New York Times
Recommended Minimum Data Elements for Radiation Oncology via ASTRO
Can Roche’s little tech startup help the FDA change clinical trials? via STAT News on Flatiron Health
Additional reading for your physicists: